Dr. Reddy's Laboratories Files 6-K Report

Ticker: RDY · Form: 6-K · Filed: Dec 20, 2024 · CIK: 1135951

Dr Reddys Laboratories LTD 6-K Filing Summary
FieldDetail
CompanyDr Reddys Laboratories LTD (RDY)
Form Type6-K
Filed DateDec 20, 2024
Risk Levellow
Pages1
Reading Time2 min
Sentimentneutral

Sentiment: neutral

Topics: reporting, sec-filing, foreign-private-issuer

TL;DR

DRL filed a 6-K, just standard reporting for investors.

AI Summary

Dr. Reddy's Laboratories Ltd. filed a Form 6-K on December 20, 2024, to report information as a foreign private issuer. The filing is in accordance with Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934. The company is based in Hyderabad, India, and its fiscal year ends on March 31.

Why It Matters

This filing indicates ongoing reporting compliance for Dr. Reddy's Laboratories, a significant player in the pharmaceutical industry, ensuring transparency for investors.

Risk Assessment

Risk Level: low — This is a routine filing for a foreign private issuer and does not contain new material financial information or strategic changes.

Key Players & Entities

FAQ

What is the purpose of this Form 6-K filing?

The Form 6-K is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used by Dr. Reddy's Laboratories Ltd. to submit information to the SEC.

When was this Form 6-K filed?

This Form 6-K was filed on December 20, 2024.

Where is Dr. Reddy's Laboratories Ltd. headquartered?

Dr. Reddy's Laboratories Ltd. is headquartered in Hyderabad, Telangana, India.

Does Dr. Reddy's Laboratories file an annual report on Form 20-F or 40-F?

The filing indicates that Dr. Reddy's Laboratories files its annual reports under cover of Form 20-F.

What is the standard industrial classification for Dr. Reddy's Laboratories?

The Standard Industrial Classification for Dr. Reddy's Laboratories is Pharmaceutical Preparations [2834].

Filing Stats: 402 words · 2 min read · ~1 pages · Grade level 16.8 · Accepted 2024-12-20 06:53:50

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. DR. REDDY’S LABORATORIES LIMITED (Registrant) Date: December 20, 2024 By: /s/ K Randhir Singh Name: K Randhir Singh Title: Company Secretary 3

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing